Schedule 13G ownership disclosure

GUIDED THERAPEUTICS INCORPORATED

Common Stock, par value $0.001 per share · CUSIP: 40171F501

Event date: 2024-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Auctus Fund Management LLC

    Shares: 5,804,865.00 · Class: 9.9%

  • Auctus Fund, LLC

    Shares: 5,804,865.00 · Class: 9.9%

  • Alfred Sollami

    Shares: 5,804,865.00 · Class: 9.9%

  • Louis Posner

    Shares: 5,804,865.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001700205-24-000005
Form type
SCHEDULE 13G/A
Filer
Auctus Fund Management LLC
CIK
CIK 1700205
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub